| Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant) EU/1/23/1752/001-006 |
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B |
Pfizer Europe MA EEIG |
— |
| Aciclovir 25mg/ml concentrate for solution for infusion PA0822/215/001 |
Aciclovir |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Aldactone 100 mg Film-coated tablets PA0822/110/003 |
Spironolactone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Aldactone 25 mg Film-coated Tablets PA0822/110/001 |
Spironolactone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Aldactone 50 mg Film-coated tablets PA0822/110/002 |
Spironolactone |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Amsparity 20 mg solution for injection in pre-filled syringe EU/1/19/1415/001 |
Adalimumab |
Pfizer Service Company BVBA |
— |
| Amsparity 40 mg solution for injection in pre-filled pen EU/1/19/1415/007-010 |
Adalimumab |
Pfizer Service Company BVBA |
— |
| Amsparity 40 mg solution for injection in pre-filled syringe EU/1/19/1415/003-006 |
Adalimumab |
Pfizer Service Company BVBA |
— |
| Amsparity 40 mg/0.8 ml solution for injection EU/1/19/1415/002 |
Adalimumab |
Pfizer Service Company BVBA |
— |
| ARICEPT 10 mg film coated tablets PA0822/002/002 |
Donepezil hydrochloride |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| ARICEPT 5 mg film coated tablets PA0822/002/001 |
Donepezil hydrochloride |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Aromasin 25 mg coated tablets PA0822/111/001 |
Exemestane |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Arthrotec 50 modified-release tablets PA0822/112/001 |
Diclofenac sodium, Misoprostol |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Arthrotec 75 modified-release tablets PA0822/112/002 |
Diclofenac sodium, Lactose monohydrate, Misoprostol |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Atgam 50 mg/ml concentrate for solution for infusion PA0822/238/001 |
Anti-T Lymphocyte Immunoglobulin for Human Use, Horse |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Ativan 1 mg Tablets PA0822/090/001 |
Lorazepam |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| BeneFIX 1000 IU powder and solvent for solution for injection EU/1/97/047/006 |
Nonacog alfa |
Pfizer Europe MA EEIG |
— |
| BeneFIX 1500 IU powder and solvent for solution for injection EU/1/97/047/009 |
Nonacog alfa |
Pfizer Europe MA EEIG |
— |
| BeneFIX 2000 IU powder and solvent for solution for injection EU/1/97/047/007 |
Nonacog alfa |
Pfizer Europe MA EEIG |
— |
| BeneFIX 250 IU powder and solvent for solution for injection EU/1/97/047/004 |
Nonacog alfa |
Pfizer Europe MA EEIG |
— |
| BeneFIX 3000 IU powder and solvent for solution for injection EU/1/97/047/008 |
Nonacog alfa |
Pfizer Europe MA EEIG |
— |
| BeneFIX 500 IU powder and solvent for solution for injection EU/1/97/047/005 |
Nonacog alfa |
Pfizer Europe MA EEIG |
— |
| BESPONSA 1 mg powder for concentrate for solution for infusion EU/1/17/1200/001 |
Inotuzumab ozogamicin |
Pfizer Europe MA EEIG |
— |
| Bosulif 100 mg film-coated tablets EU/1/13/818/001-002 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 100 mg hard capsules EU/1/13/818/009 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 400 mg film-coated tablets EU/1/13/818/006-007 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 50 mg hard capsules EU/1/13/818/008 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 500 mg film-coated tablets EU/1/13/818/003-004 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Cabaser 1 mg Tablet PA0822/114/001 |
Cabergoline |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| CAMPTO 20 mg/mL concentrate for solution for infusion PA0822/212/001 |
Irinotecan hydrochloride trihydrate |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Caverject 10 micrograms Powder and Solvent for Solution for Injection PA0822/115/002 |
Alprostadil |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Caverject 20 micrograms Powder and Solvent for Solution for Injection PA0822/115/003 |
Alprostadil |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Champix 0.5 mg Film-coated tablet EU/1/06/360/01 |
Varenicline tartrate |
Pfizer Europe MA EEIG |
— |
| Champix 0.5mg & 1mg Film-coated tablets EU/1/06/360/003 |
Varenicline |
Pfizer Europe MA EEIG |
— |
| Champix 1 mg Film-coated tablet EU/1/06/360/02 |
Varenicline tartrate |
Pfizer Europe MA EEIG |
— |
| Cibinqo 100 mg film-coated tablets EU/1/21/1593/006-010 |
Abrocitinib |
Pfizer Europe MA EEIG |
— |
| Cibinqo 200 mg film-coated tablets EU/1/21/1593/011-015 |
Abrocitinib |
Pfizer Europe MA EEIG |
— |
| Cibinqo 50 mg film-coated tablets EU/1/21/1593/001-005 |
Abrocitinib |
Pfizer Europe MA EEIG |
— |
| Cisplatin 1 mg/ml Concentrate for Solution for Infusion PA0822/199/001 |
Cisplatin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| CONBRIZA 20 mg Film-coated tablet EU/1/09/511/1-4 |
Bazedoxifene |
Pfizer Europe MA EEIG |
— |
| Cyklokapron 100 mg/mL solution for injection/infusion PA0822/117/001 |
Tranexamic acid |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Cytarabine 100 mg/ml Solution for Injection PA0822/200/002 |
Cytarabine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Cytarabine 20 mg/ml Solution for Injection or Infusion PA0822/200/001 |
Cytarabine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Cytotec 200 microgram tablets PA0822/118/001 |
Misoprostol |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin 100 mg Vaginal Ovule PA0822/119/001 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Dalacin 2% vaginal cream PA0822/119/002 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin C 150 mg Hard Capsules PA0822/120/001 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin C Phosphate 150 mg/ml Concentrate for Solution for injection/infusion, 2ml PA0822/120/002 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin C Phosphate 150 mg/ml Concentrate for Solution for injection/infusion, 4ml PA0822/120/003 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin T Topical Lotion 10 mg/ml Cutaneous Emulsion PA0822/121/001 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |